USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
      Featured
      Our Next Event
      Register for LSI USA ‘26
      500+ Investors & Strategics
      See LSI USA '26 Attendee List
      Events Overview
      • Our Summits
      • Who Attends
      • Why Present
      Upcoming Summits
      • LSI USA ‘26
      • LSI Asia ‘26
      • LSI Europe '26
      Past Summits
      • LSI USA ‘25
      • LSI Asia ‘25
      • LSI Europe ‘25
      • Archives
  • Insights
      Featured
      Just Launched
      Compass AI
      New Report
      Emerging Innovators Report
      Compass Al
      Emerging Innovators Report
      Market Data
      Custom Research
  • Magazine
      Featured
      February Edition
      Explore Latest Editions
      The Lens Magazine
      Start Your Subscription
      Magazine
      • The Lens Magazine
      • Explore the Newest Edition
      • Read Free Articles
  • Resources
      Featured
      Released Weekly
      The LSI Alumni Weekly Recap
      Just Released
      2025 LSI Alumni Funding Report
      Resources
      • Research Desk
      • Testimonials
      • Video Library
      • Photo Gallery
  • Company
      Featured
      Our Next Event
      Register for LSI USA '26
      Just Launched
      Compass AI
      Company
      • About Us
      • Our Team
      • Press
  • Contact Us
Contact Us
USA Europe Asia
Compass AI Login Medtech Pro Login
  • Events
  • Insights
  • Magazine
  • Resources
  • Company
Events Overview
  • Our Summits
  • Who Attends
  • Why Present
Upcoming Summits
  • LSI USA ‘26
  • LSI Asia ‘26
  • LSI Europe ‘26
Past Summits
  • LSI USA ‘25
  • LSI Asia ‘25
  • LSI Europe ‘25
  • Archives
Featured
Our Next Event
Register for LSI USA '26
350+ Investors & Strategics
See LSI USA '26 Attendee List
Compass Al
Emerging Innovators Report
Market Data
Custom Research
Featured
Just Launched
Compass AI
New Report
Emerging Innovators Report
Magazine
The Lens Magazine
Explore the Newest Edition
Read Free Articles
Featured
February Edition
Explore Latest Editions
The Lens Magazine
Start Your Subscription
Resources
Research Desk
Testimonials
Video Library
Photo Gallery
Featured
Released Weekly
The LSI Alumni Weekly Recap
Just Released
2025 LSI Alumni Funding Report
Company
About Us
Our Team
Press
Featured
Our Next Event
Register for LSI USA '26
Just Launched
Compass AI
Join our Next Event
LSI USA ‘26, March 16-20, 2026
Waldorf Astoria, Monarch Beach
Register Today
Compass AI
The medtech-specific AI
research platform by LSI
Demo Compass AI
The Lens Magazine
The Lens Medtech
Magazine is LSI's most
curated industry coverage.
  1. Video Library
  2. Changing Leadership Culture in Real Time at RefleXion Medical – A Case Study | LSI USA '24

Changing Leadership Culture in Real Time at RefleXion Medical – A Case Study | LSI USA '24

With large organizations struggling to iterate changes in an effective and time efficient manner, this panel talks about a problem solving methodology to align a company's employees in order to make those change quickly.
Share social-facebook social-x social-linkedin
Speakers
Ed Muzio
Ed Muzio
Group Harmonics
Bio Bio
Todd Powell
Todd Powell
RefleXion Medical
Bio Bio
View Video Transcript
lsi logo
Contact Us

Upcoming Events

LSI USA ‘26
LSI USA ‘26
March 16-20, 2026
Dana Point, CA
LSI ASIA ‘26
LSI ASIA ‘26
June 30 - July 2, 2026
Singapore
LSI EUROPE ‘26
LSI EUROPE ‘26
Sept 28 - Oct 1, 2026
Barcelona

More From LSI

  • Attend an Event
  • Sponsor an Event
  • Compass, by LSI
  • The Lens, Magazine by LSI

Resources

  • Research Desk
  • Photo Gallery
  • Video Library
  • Testimonials
  • About Us

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy

Request Info
close
STEP 1
close-icon
The Lens - Complimentary Issue
close
close

Subscription Includes

Request Info

Global Medtech Market Analysis & Projections (MAP), 2021-2031
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf report

The Global Medtech Market Analysis and Projections (MAP) provides global market forecasts (2021 – ’31), share-by-supplier data, and analyst insights on 23 major device markets (e.g., Cardiovascular, Orthopedics, Neurovascular, In-Vitro Diagnostics) and 200+ technology subsegments. Understand major market trends and projections across the medtech industry with what medtech strategics and consulting firms have referred to as their “gold standard” for device market sizing data.

Global Surgical Procedure Volumes Dashboard, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Global Surgical Procedure Volumes database is the single source of truth for understanding diagnostic and therapeutic procedure volumes on a global scale. With coverage on 37 countries, including the United States, Europe’s Big Five, China, India, Japan and more for 12 major procedure markets (Cardio, Ortho, General Surgery, Radiosurgery, Neuro, OB/GYN and more), this fully interactive database is designed to facilitate one-to-one analyses of procedures, countries, and regions. Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

United States Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United States Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United States. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Aesthetics, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Aesthetics Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Aesthetics Procedures Database covers major aesthetic procedures, including: Biopsies, Punch Biopsies, Shave Biopsies, Incisional Biopsies, Lesion Removal Procedures, Curettage, electrocautery, and electrocoagulation lesion destruction, Photodestruction, Cryotherapy-based lesion destruction, Lesion Removal Procedures: Traditional and Other, Abdominoplasty, Blepharoplasty, Breast Augmentation, Breast Lift, Breast Reduction, Buttock Augmentation, Buttock Lift, Cheek Implants, Chin Augmentation, Facelift, Forehead Lift, Gynecomastia Treatment, Hair Transplantation, Lip Augmentation, Liposuction, Lower Body Lift, Otoplasty, Rhinoplasty, Thigh Lift, Upper Arm Lift, Vaginal Rejuvenation, Surgeries for Cleft Palate and Lip, Surgeries for Burn Injuries.

Cardio, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Cardiothoracic and Interventional Cardiology Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Cardiothoracic and Interventional Cardiology Procedures Database covers major cardiothoracic and interventional cardiology procedures, including: CABG Surgeries Off-Pump CABG, On-Pump CABG, Valve Procedures Aortic Valve Replacements, Mitral Valve Replacements, MV Repairs, AV Repairs, PV Replacements, PV Repairs, TV Operations, Percutaneous Valvuloplasties, Percutaneous Valve Replacements, CHD Surgeries Ventricular Septal Defect Closures, Patent Ductus Arteriosus Repairs, Atrial Septal Defect Closures, Repair of Tetralogy of Fallot, Arterial Shunts Surgeries, Atrioventricular Septal Defect Repairs, Transposition of Great Artery Procedures, Anomalous Pulmonary Venous Return Repairs, Other Congenital Heart Disease Surgeries, Other Cardiothoracic Surgeries Aortic Aneurysm Procedures, Other Cardiothoracic Surgeries, Diagnostic and Therapeutic Catheterizations, Stand-Alone Diagnostic Cardiac Catheterizations, Percutaneous Coronary Interventions, Coronary Interventions Radial Approach, Coronary Interventions Femoral Approach, Heart Rhythm Procedures Conventional Pacemaker Procedures, ICD Procedures, Cardiac Resynchronization Device Procedures, Combined Defib/Resynch Device Procedures, Cardiac Ablations.

ENT, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ear, Nose, and Throat Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ear, Nose, and Throat Surgical Procedures Database covers major ear, nose, and throat procedures, including: Tonsillectomies, Operations on the Ear, FESS, Tracheostomies, Thyroidectomies & Parathyroidectomies, Stand-Alone Adenoidectomies, Tongue Operations, Laryngeal Operations, Pharyngeal Operations, Radical Neck Dissection.

General, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The General Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The General Surgeries Procedures Database covers major general surgical procedures, including: Cholecystectomies Laparoscopic Cholecystectomies, Open Cholecystectomies, Appendectomies, Laparoscopic Appendectomies, Open Appendectomies, Herniorrhaphies Laparoscopic Herniorrhaphies, Open Herniorrhaphies, Bariatric Surgeries Laparoscopic Bariatric, Open Bariatric, Selected Other Endoscopic General & Colorectal Procedures Esophageal (Other Endoscopic), Stomach & Intestinal (Other Endoscopic), Colorectal (Other Endoscopic), Liver (Other Endoscopic), Gallbladder & Biliary (Other Endoscopic), Pancreatic (Other Endoscopic), Other (Other Endoscopic), Other Surgeries Esophageal (Other General, non-Endoscopic), Stomach & Intestinal (Other General, non-Endoscopic), Colorectal (Other General, non-Endoscopic), Liver (Other General, non-Endoscopic), Gallbladder & Biliary (Other General, non-Endoscopic), Pancreatic (Other General, non-Endoscopic), Other (Other General, non-Endoscopic).

Neuro, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Neurosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Neurosurgery Procedures Database covers major neurosurgical procedures, including: Surgeries for Traumatic Brain Injuries, Ventricular & Shunt Surgeries, New Shunt Placements, Revision Shunt Surgeries, Endoscopic Third Ventriculostomies, Diagnostic Ventricular Endoscopies, Vascular Lesion Procedures, Vascular Lesion Surgeries, Vascular Lesion Coil Procedures, Pituitary Tumor Surgeries, Open Pituitary Tumor Surgeries, Endoscopic Pituitary Tumor Surgeries, Intracranial Tumor Surgeries, Open Intracranial Tumor Surgeries, Endoscopic Intracranial Tumor Surgeries, Cranioplasties, Intracranial Neurostimulation and Peripheral Nerve Procedures, Intracranial Neurostimulator Implant Procedures, Peripheral Nerve Neurostimulation Procedures, Other Peripheral Nerve Procedures.

OB/GYN, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Obstetric and Gynecological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Obstetric and Gynecological Surgical Procedures Database covers major obstetric and gynecological procedures, including: Obstetrical Surgeries Cesarean Sections, Destructive Operations, Episiotomies, Other Obstetrical Surgeries, Gynecological Surgeries Colposcopies, Hysterectomies, Salpingo-Oophorectomies & Oophorectomies, Colposcopies, Salpingo-Oophorectomies & Oophorectomies, Hysterectomies, Total Hysterectomies, Subtotal Hysterectomies, Vaginal Hysterectomies, Breast Cancer Surgeries, Breast Reconstruction Surgeries, Breast-Conserving Surgeries, and Mastectomies, among other surgeries.

Ophthalmology, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Ophthalmological Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Ophthalmological Surgical Procedures Database covers major ophthalmological procedures, including: Cataract Surgeries, Phacoemulsification Surgeries, ICCE Surgeries, ECCE Surgeries, MSICS Surgeries, Refractive Surgeries.

Orthopedic, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Orthopedic Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Orthopedic Surgical Procedures Database covers major orthopedic procedures, including: Hip Arthroplasties Revision Hip Arthroplasties, Hip Resurfacing Procedures, Primary Hip Arthroplasties - Total Hip, Partial Hip, Knee Arthroplasties Revision Knee Arthroplasties, Primary Knee Arthroplasties - Partial Knee, Primary Knee Arthroplasties - Total Knee, Extremity Fractures Using Hardware Extremity Fractures Using Hardware - Upper Extremities, Extremity Fractures Using Hardware - Fractures of the Femoral Neck & Shaft, Extremity Fractures Using Hardware - Other Lower Extremity, Arthroscopies Knees (Arthroscopies), Shoulders (Arthroscopies), Ankles (Arthroscopies), Feet & Toes (Arthroscopies), Others (Arthroscopies), Other Joint Arthroplasties Finger & Hand, Wrist, Elbow, Shoulder, Ankle & Foot.

Peripheral Vascular, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Peripheral Vascular Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Peripheral Vascular Surgeries Procedures Database covers major peripheral vascular procedures, including: Arterial Procedures Thrombectomies & Thromboendarterectomies, Carotid Artery Thrombectomies, Upper Limb Artery Thrombectomies, Iliac Artery Thrombectomies, Renal Artery Thrombectomies, Lower Limb Artery Thrombectomies, Arterial Angioplasties, Carotid Artery Angioplasties, Upper Limb Artery Angioplasties, Iliac Artery Angioplasties, Renal Artery Angioplasties, Lower Limb Artery Angioplasties, Arterial Bypasses, Carotid Artery Bypasses, Upper Limb Artery Bypasses, Iliac Artery Bypasses, Renal Artery Bypasses, Aortofemoral and Aortobifemoral Bypasses, Femoropopliteal Bypasses, Femorotibeal Bypasses, Other Lower Limb Bypasses, Venous Procedures Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies of Dialysis Access Venous Segments, Thrombectomies & Thromboendarectomies of Other Upper Limb Veins, Angioplasties of Dialysis Access Venous Segments, Angioplasties of Head, Neck and Other Upper Limb Veins, Lower Limb Venous Procedures Removals of the Saphenous Vein, Removals of Other Veins of the Lower Limbs.

Spine, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spine Surgical Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Spine Surgical Procedures Database covers major spine procedures, including: Cervical Spine Surgeries Cervical Spine Decompressions, Cervical Spine Discectomies, Cervical Spine Fusions, Cervical Spine Disc Replacements, Thoracic and Deformity Procedures Thoracic Spine Decompressions, Thoracic Spine Discectomies, Thoracic Spine Fusions, Instrumented Procedures for Deformities, Lumbar Procedures Lumbar Spine Decompressions, Lumbar Spine Discectomies, Lumbar Spine Fusions, Insertion of Lumbar Interspinous Process Spacer, Lumbar Spine Disc Replacements, Vertebroplasties & Kyphoplasties Vertebroplasties, Kyphoplasties, Other Spine Surgeries.

SRS, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Stereotactic Radiosurgery Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Stereotactic Radiosurgery Procedures Database covers major stereotactic radiosurgery procedures, including: Intracranial SRS Procedures, Extracranial SRS Procedures, Extracranial Spine Procedures, Extracranial Lung Procedures, Other Extracranial Procedures.

Urological, Global Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Urological Surgeries Procedure Volumes Dashboard provides global, regional, and country-specific historical and projected procedure volumes forecasts from 2018 to 2029. The Urological Surgeries Procedures Database covers major urological procedures, including: Kidney Stone Procedures Extra Corporeal Shock Wave Lithotripsy, Percutaneous Nephro Lithotripsy, Ureteroscopies, Open Kidney Stone Procedures, BPH Procedures Transurethral Prostatectomies, Other BPH Surgeries, Prostatectomies, Nephrectomies Partial Nephrectomies, Radical Nephrectomies, Bladder Procedures Therapeutic Endoscopies, Diagnostic Endoscopies, Urethral Catheterizations of Bladder.

Global Markets for Hip Replacement Implants, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for hip replacement implants. The market for hip replacement implants includes all prosthetic devices used to replace damaged sections of the hip joint, including those used in total and semi/hemi replacement procedures. This market snapshot is intended to provide a high-level overview of the global market for hip replacement implants, with key insights into: Procedure volumes from 2022 to 2028, Market forecasts from 2022 to 2028, Competitive landscape analysis of major competitors, Insights into key market events for strategics and startups. Companies covered in this report include: B. Braun, DePuy Synthes, DJO Global, Exactech, Johnson & Johnson, Medacta, MicroPort Scientific, Ortho Development, OSSIS, SERF SAS, Smith+Nephew, Symbios Orthopedie, Total Joint Orthopedics, Zimmer Biomet.

Global Markets for Peripheral Vascular Guidewires, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Atherectomy Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Electrosurgery, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Peripheral Vascular Balloons & Vena Cava Filter, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for percutaneous transluminal angioplasty (PTA) balloons and inferior vena cava (IVC) filters. A PTA balloon is used in the treatment of peripheral artery disease (PAD) to open a narrowed or blocked artery. IVC filters are permanent or temporary devices to prevent the travel of thrombotic material to the lungs. These devices are frequently used in the management of patients with severe PAD. This market snapshot is intended to provide a high-level overview of the global market for PTA balloons and IVC filters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Acotec Scientific, Adient Medical, B. Braun, BD, Biotronik, Boston Scientific, Brosmed, Cagent Vascular, Cardinal Health, CONMED, Cook Medical, Concept Medical, Cordis, Covellus, Degania Medical, iVascular, Medtronic, Merit Medical, NextStep Medical, Nipro, OrbusNeich, Orchestra BioMed, Philips, Terumo, TriReme Medical.

Global Markets for Mechanical Heart Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Tissue Heart Valve Replacement, 2023-2028
Published:
2023
Next Update:
Q2 2030
Deliverables:
excel pdf

Description coming soon.

Global Markets for Transcatheter Mitral Valve Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Femoral Closure, 2023-2029
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for femoral closure devices. Femoral closure devices are used to achieve hemostasis of the hole in the artery that is created to perform catheter-based cardiovascular or endovascular procedures. This market snapshot is intended to provide a high-level overview of the global market for femoral closure devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Cardinal Health, Cardiva, Cordis, CyndRx, Endocor, Haemonetics, Morris Innovative, Rex Medical, Teleflex, Terumo, Transluminal Technologies, Vasorum, Vivasure Medical.

Global Markets for Tricuspid Valve Repair, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for tricuspid valve repair devices. Tricuspid valve repair is the preferred surgical approach for the treatment of degenerative tricuspid valve disease. The market is currently experiencing a renaissance with the introduction and development of transcatheter solutions for tricuspid valve repair and replacement. Devices covered within the scope of this analysis include tricuspid valve annuloplasty rings and transcatheter tricuspid valve repair devices. This market snapshot is intended to provide a high-level overview of the global market for tricuspid valve repair devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, CroiValve, Edwards Lifesciences, Innoventric, Medtronic, Mitral Holdco, Mitralix, NaviGate, OrbusNeich, TriCares, Venus Medtech.

Global Markets for Percutaneous Pulmonary Valves, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement. This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Edwards Lifesciences, Medtronic, PolyVascular, Venus Medtech.

Global Markets for Coronary Angio Guidewires & Catheters, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for coronary angiography catheters and guidewires. These devices are essential to perform coronary angiography, a minimally invasive medical procedure used to visualize blood flow, identify blockages and narrowing of the coronary arteries. Devices covered within the scope of this analysis include coronary angiography catheters and coronary angiography guidewires. This market snapshot is intended to provide a high-level overview of the global market for coronary angiography catheters and guidewires, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AngioDynamics, B. Braun, Boston Scientific, Cardinal Health, Cook Medical, Cordis, Medtronic, Merit Medical, Philips, Teleflex, Terumo.

Global Markets for Oncology Ablation Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology ablation catheters. These devices are used as a therapeutic modality employing energy to selectively destroy cancerous tissue. Devices covered within the scope of this analysis include radiofrequency and microwave ablation electrodes, excluding cryoablation devices, which are covered in a separate report. The snapshot offers a high-level overview of the global market for oncology ablation catheters and guidewires, with key insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: AngioDynamics, Baylis, Boston Scientific, Canyon Medical, CAPS Medical, EDAP, Galvanize Therapeutics, Imagin Medical, Medtronic, Mermaid, Mirai Medical, Monteris, Sonablate, Stryker, TROD Medical, and US Medical Innovations.

Global Markets for ENT Devices, 2023-2028
Published:
2023
Next Update:
Q2 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for endoscopic devices for ear, nose, and throat (ENT) surgery. These devices are used to examine and operate on the structures and tissues in the ear, nose, and throat. Devices covered within the scope of this analysis include ENT endoscopic surgical instruments, balloon sinus and dilation catheters, and rigid endoscopes and bronchoscopes. This market snapshot is intended to provide a high-level overview of the global market for ENT endoscopic surgery devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: 3NT Medical, Acclarent, Conmed, Endoluxe, Entellus Medical, Intuitive Surgical, Johnson & Johnson, KARL STORZ, Medtronic, Olympus, Pentax, Pristine Surgical, Richard Wolf, Smith & Nephew, Stryker, Tympany Medical.

Global Markets for Cell Delivery Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. Devices covered within the scope of this analysis include cell delivery catheters. This market snapshot is intended to provide a high-level overview of the global market for cell delivery catheters, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: BioCardia, Biosense Webster, Boston Scientific, Cordis, Medtronic, Mercator MedSystems, TriSalus Life Sciences, TRI Medical.

Global Markets for Urology Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for urology and renal devices, focusing on treatments for six major conditions: End-stage renal disease (ESRD), Incontinence, Calculi (stones), Benign prostatic hyperplasia (BPH), Prostatitis, and Erectile dysfunction (ED). The devices covered within this analysis encompass a range of tools for diagnosis, treatment, and management, including urinary bags, foley catheters, catheter insertion kits, intermittent catheters, endourology devices, BPH ablation devices, lithotripsy devices, and artificial penis devices. The snapshot provides key insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for strategics and startups. Companies covered in this report include: 3M, Applied Medical, Astratech, Balton, Baxter Healthcare, B. Braun, BD, Boston Scientific, Calyxo, Corinth Medtech, Coloplast, EndoMed, Flume Catheter Company, Hollister, ICU Medical, Karl Storz, Medline, Medtronic, Merit Medical, Nipro, Olympus, SonoMotion, Teleflex, and Urovision.

Global Markets for External Pain Pumps, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for external pain pumps. These devices are used to provide patients with consistent, long-lasting pain relief by delivering pain medication epidurally, intravenously, or subcutaneously. Devices covered within the scope of this analysis include external infusion pumps for pain management. This market snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Avanos, B. Braun, BioQ Pharma, Epic Health, ICU Medical, InfuTronix, Medical Flow Systems, Medipacs, MicroPort, Smiths Medical, Teleflex.

Global Markets for Ureteral Access Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence delves into the global market for ureteral access devices, crucial components utilized alongside ureteroscopy or percutaneous nephrolithotomy procedures. These devices facilitate dilation and create a working channel for various urologic interventions. The snapshot aims to offer insights into unit volumes and market forecasts spanning from 2023 to 2028. Additionally, it provides a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Amecath, Applied Medical, BD, Boston Scientific, Cook Medical, Envaste, Johnson & Johnson, Mednova, Olympus, Richard Wolf, Rocamed, Teleflex, and Terumo.

Global Markets for Pelvic Floor Repair, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for pelvic floor repair mesh. These products are used during surgical procedures to repair prolapse and urinary incontinence. Devices covered within the scope of this analysis include pelvic floor repair/reconstruction mesh. This market snapshot is intended to provide a high-level overview of the global market for pelvic floor repair mesh, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: BD, Boston Scientific, Coloplast, Cook Medical, Ethicon, Johnson & Johnson.

Global Markets for Atrial Fibrillation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Neurovascular Devices Ischemic, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence analyzes the global market for devices used in the treatment of ischemic stroke, focusing on solutions designed to remove occlusions in blood vessels to prevent and treat this condition. The market snapshot offers insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Cerenovus, Ceretrieve, Cordis, InNeuroCo, Julier, Medtronic, MicroPort Scientific, Microvention, Penumbra, Phenox, Poseydon Medical, Route 92 Medical, Stryker, and Terumo.

Global Markets for Neuromodulation Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global neuromodulation market – a thriving market for managing and treating neurological diseases, chronic pain, and other chronic conditions. Types of neuromodulation, or neurostimulation, devices include implantable and transcutaneous devices, including wearable devices. This market snapshot is intended to provide a high-level overview of the global neuromodulation market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bionics, Alyve Medical, Axonics, Biotronik, Boston Scientific, EBT Medical, electroCore Medical, Inspire Medical, LivaNova, Medtronic, Neuromod Devices, Nevro.

Global Markets for Vertebroplasty Devices, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vertebral augmentation products, which are crucial in treating vertebral compression fractures, often caused by osteoporosis or spinal tumors. Vertebroplasty and kyphoplasty are the primary surgical interventions, and the market includes products such as vertebroplasty and kyphoplasty cement, as well as delivery devices. The snapshot aims to provide a comprehensive overview of the global vertebral augmentation products market, with key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Halma, IZI Medical, Medtronic, Mendec, Merit Medical, RevBio, and Stryker.

Global Markets for TAVI/TAVR, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Drug Delivery, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

Global Markets for Benign Prostation Hyperplasia Implants, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hypertrophy/hyperplasia (BPH). These implants are reversible solutions for men suffering from lower urinary tract symptoms (LUTS) caused by prostate enlargement. This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Butterly Medical, Endotherapeutics, Olympus, ProArc, ProVerum, Teleflex, Urotronic, ZenFlow.

Global Markets for Cryoablation, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for cryoablation devices for non-cardiovascular applications. These devices are used to freeze and induce cellular damage and death for indications including cancer, dermatological conditions, peripheral vascular disease, and urological conditions. This market snapshot is intended to provide a high-level overview of the global cryoablation devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Boston Scientific, Brymill Cryogenics, Channel Medsystems, CooperSurgical, CPSI Biotech, CryoConcepts, CryoProbe, CryoSurgery, CSA Medical, Endocare, Endocision, Grand Cryo, Ictero Medical, KryoLife, Mectronic Medical, Sedivention, Siemens Healthineers, Varian Medical Systems, Wallach Surgical.

Global Markets for Diagnostic Electrophysiology Catheters, 2023-2028
Published:
2023
Next Update:
Q3 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a high growth phase due to improving technology for the surgical treatment of cardiac arrhythmias and atrial fibrillation (AF). This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AccuPulse, Acutus Medical, BD, Biosense Webster, Boston Scientific, CardioNXT, CoreMap, Johnson & Johnson, Kardium, Medtronic, MicroPort Scientific, Stereotaxis.

Global Markets for Hernia Repair, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence (LSI) provides an analysis of the global market for hernia mesh products for the surgical repair of hernias. The global market for hernia mesh products is projected to see moderate growth throughout the forecast period covered by the analysis. While the market has been negatively impacted by ongoing lawsuits associated with product complications, the next generation of products has helped the market to recover for one of the most performed abdominal surgeries. This market snapshot is intended to provide a high-level overview of the global market for hernia mesh products, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Allergan, Ariste Medical, BD, Cook Medical, Deep Blue Medical Advances, Ethicon, Exogenesis, Integra Lifesciences, Johnson & Johnson, LifeCell, Medtronic, Novus Scientific, Tarian Medical, TELA Bio, TISSIUM, W.L. Gore.

Global Markets for CRM Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure. This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, AtaCor Medical, BioTrace Medical, Biotronik, Boston Scientific, Cairdac, Electroducer, FineHeart, Lepu Medical, LivaNova, Medico, Medtronic, Merit Medical, Microport Scientific, Osypka Medical, Pacetronix.

Global Markets for Neurovascular Devices Hemorrhagic, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This report from Life Science Intelligence provides an analysis of the global market for neurovascular devices for the treatment of hemorrhagic stroke. These solutions are used to treat intracerebral bleeds, ruptured aneurysms, and other neurovascular deformities that lead to the pooling of blood vessels that have ruptured inside and outside of the brain. This market snapshot is intended to provide a high-level overview of the global market for neurovascular devices for hemorrhagic stroke, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Acandis, Artio Medical, Endostream Medical, Medtronic, MicroPort Scientific, Microvention, Phenox, Penumbra, Rapid Medical, Shape Memory Medical, Stryker, Terumo, Wallaby Medical.

Global Markets for Renal Denervation, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for renal denervation devices for the treatment of refractory hypertension (i.e., high blood pressure that does not respond to pharmaceuticals). The market for renal denervation devices includes radiofrequency and ultrasound catheters which are used to ablate the renal nerves. This market snapshot is intended to provide a high-level overview of the global market for renal denervation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Ablative Solutions, Brattea, Medtronic, Metavention, Otsuka Medical, ReCor Medical, SoniVie.

Global Markets for Upper+Lower Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence analyzes the global market for suture anchors used in upper and lower extremity repair and reconstruction procedures. Suture anchors play a critical role in securing soft tissue to bone, particularly for severe soft tissue tears. The market encompasses bioabsorbable, biocomposite, metallic, and PEEK suture anchors. The snapshot aims to offer insights into unit volumes and market forecasts from 2023 to 2028, along with a competitive landscape analysis of major competitors and key market events for strategics and startups. Companies covered in this report include: Acumed, Acuitive Technologies, aevumed, Anika Therapeutics, Arthrex, ConMed, DePuy Synthes, Johnson & Johnson, Mitek, OSSIO, Paragon 28, Responsive Arthroscopy, Riverpoint Medical, Smith & Nephew, Stryker, and Zimmer Biomet.

Global Markets for Peripheral Stents, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for biliary and peripheral vascular stents. These devices are used to maintain and restore patency to anatomical ducts or vessels that have become obstructed due to the formation of plaque, narrowing of the natural lumen, or presence of benign and malignant growths. This market snapshot is intended to provide a high-level overview of the global peripheral vascular and biliary stents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Abbott, BD, Biotronik, Boston Scientific, Bryan Medical, Cardinal Health, Cook Medical, Cordis, Endo GI Medical, Hood Labs, Maquet, Medtronic, Merit Medical, MicroPort Scientific, Olympus, Q3 Medical, Zorion Medical.

Global Markets for Electromagnetic Navigation Systems, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for electromagnetic navigation systems for tracking, guiding, and positioning instruments during surgery. These systems provide surgeons and the surgical team with real-time information on the position and orientation of instruments used during open and minimally invasive surgeries. This market snapshot is intended to provide a high-level overview of the global electromagnetic navigation systems market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Brainlab, Collin Medical, Elucent Medical, Fiagon, Heal Force, Joimax, Karl Storz, Medtronic, Olympus, Stryker, Veran Medical Technologies.

Global Markets for GI Endoscopy, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot report from Life Science Intelligence provides an analysis of the global market for gastrointestinal (GI) endoscopic devices. These devices are used to visualize, diagnose, and surgically treat conditions of the GI tract. The market for GI endoscopic devices includes endoscopes and endoscopic instruments. This market snapshot is intended to provide a high-level overview of the global market for GI endoscopic devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Ambu, Applied Medical, Aqua Medical, Aspero Medical, B. Braun, Boston Scientific, ConMed, Endoluxe, Ethicon, Integra Lifesciences, Intuitive Surgical, IQ Endoscopes, Johnson & Johnson, Karl Storz, Medtronic, MiWendo Solutions, Olympus, Purple Surgical, Richard Wolf, Stryker, Teleflex.

Global Markets for Hemodialysis, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for hemodialysis solutions. Hemodialysis is an essential treatment for patients suffering from end-stage renal disease due to kidney failure. Hemodialysis systems, catheters, and dialyzers are components integral to hemodialysis treatment. This market snapshot is intended to provide a high-level overview of the global hemodialysis solutions market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Asahei Kasei, AngioDynamics, B. Braun, Baxter, Bellco, Byonyks, Diality, Fresenius, Hemoclean, Humacyte, Intermedt, Inspira Health, iRen-MEDICAL, Medivators, Merit Medical, NextKidney, Nikkiso, Nipro, Rockwell Medical, Telelfex, Terumo, Toray Medical, TVA Medical, Vantive.

Globals Markets for Cardiac Ablation, 2023-2028
Published:
Next Update:
Deliverables:

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac ablation devices, which are used for the treatment of arrhythmic heart conditions, such as atrial fibrillation. The market for cardiac ablations devices is projected to see strong growth throughout the forecast period covered by this analysis, driven by demographic trends and the adoption of new technologies for the treatment of new ablation technologies, such as Pulsed Field Ablation. Devices covered within the scope of this analysis include cardiac ablation catheters. This market snapshot is intended to provide a high-level overview of the global market for cardiac ablation devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Adagio Medical, AtriAN Medical, AtriCure, Biosense Webster, Boston Scientific, Electrophysiology Frontiers, Field Medical, Galvanize Therapeutics, Healium Medical, Johnson & Johnson, Medtronic, Stereotaxis.

Global Markets for Atrial Septal Occlusion, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for atrial septal occlusion devices. These devices are used to close atrial septal defects (ASDs), an abnormal hole in the wall of the upper chambers of the heart that are present at birth. This market snapshot is intended to provide a high-level overview of the global ASD occlusion devices market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, atHeart Medical, Cardia, Hanyu Medical, Lifetech Scientific, Occlutech, W.L. Gore.

Global Markets for Aortic Grafts, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for aortic stent grafts for the treatment of aortic aneurysm. The market for aortic stent grafts includes open (surgical) and endovascular (transcatheter) aortic stent grafts used in the repair of abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). This market snapshot is intended to provide a high-level overview of the global market for aortic stent grafts, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Cook Medical, Endoron, Endospan, Lombard Medical, Medtronic, MicroPort Scientific, Taurus Vascular, Terumo, TripleMed, W.L. Gore.

Global Markets for Interventional Cardiology Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for interventional cardiology devices for the treatment of cardiovascular diseases such as heart failure or severe atherosclerosis. The market for interventional cardiology devices includes devices used to diagnose and treat diseases related to the coronary arteries. Devices included within the scope of this report include coronary stents, catheters, angioplasty balloons, guidewires, and intravascular ultrasound catheters. This market snapshot is intended to provide a high-level overview of the global market for interventional cardiology devices, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, insights into key market events for strategics and startups. Companies covered in this report include: Abbott, Advanced Bifurcation Systems, B. Braun, BD, Boston Scientific, Cardinal Health, Cook Medical, Corflow Therapeutics, Fastwave Medical, Lemaitre Vascular, Medtronic, Merit Medical, MicroPort Scientific, NirvaMed, Philips, Teleflex, Terumo, Translumina.

Global Markets for Oncology Embolization, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization, and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death. This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: ABK Biomedical, Arsenal Medical, Boston Scientific, Cook, Cordis/Cardinal Health, Instylla, Medtronic, Merit Medical, Ned Medical, Obsidio, SirTex Medical, Stryker, Terumo, Varian.

Global Markets for Vascular Access Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from Life Science Intelligence offers an analysis of the global market for vascular access devices, which are essential for continuous and long-term access to the bloodstream for administering intravenous drugs and fluids. The market encompasses various types of devices, including peripherally inserted central catheters (PICC), midline catheters, central venous catheters (CVC), and implantable ports. The snapshot aims to provide a comprehensive overview of the global market for vascular access devices, offering key insights into unit volumes and market forecasts from 2023 to 2028. Additionally, it includes a competitive landscape analysis of major competitors and insights into key market events for both established players and startups. Companies covered in this report include: Access Vascular, AngioDynamics, B. Braun, Baxter, Becton, Dickinson & Company (BD), Bluegrass Vascular, C.R. Bard, Cook Medical, ICU Medical, Medline, Smiths Medical, Teleflex, Terumo, Vygon, and Yushin Medical.

Global Markets for Rotator Cuff Repair Suture Anchors, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

This market snapshot from LSI provides an analysis of the global market for rotator cuff repair suture anchors for the treatment of rotator cuff injuries. The market for rotator cuff repair suture anchors includes anchors composed of biocompatible polymers and metals. This market snapshot is intended to provide a high-level overview of the global market for rotator cuff repair suture anchors, with key insights into: unit volumes from 2023 to 2028, market forecasts from 2023 to 2028, competitive landscape analysis of major competitors, and insights into key market events for strategics and startups. Companies covered in this report include: Aevumed, Arthrex, Atreon Orthopedics, ConMed, DePuy Synthes, Embody, Inovedis, Smith & Nephew, Stryker, Tetrous, Wright Medical, Zimmer Biomet.

Global Markets for Electrical Stimulation Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Wearable Monitoring Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Global Markets for Low Complexity Medical Devices, 2023-2028
Published:
2023
Next Update:
Q4 2024
Deliverables:
excel pdf

Description coming soon.

Canada Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Canada Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Canada. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Germany Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Germany Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Germany. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

France Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The France Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for France. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

U.K. Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The United Kingdom Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the United Kingdom. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Italy Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Italy Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Italy. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Spain Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Spain Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Spain. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Poland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Poland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Poland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Netherlands Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Netherlands Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Netherlands. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Belgium Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Belgium Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Belgium. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Sweden Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Sweden Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Sweden. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Switzerland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Switzerland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Switzerland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Denmark Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Denmark Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Denmark. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Finland Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Finland Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Finland. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Norway Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Norway Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Norway. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

China Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The China Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for China. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

India Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The India Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for India. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Japan Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Japan Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Japan. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Korea Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Korea Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Korea. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Australia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Australia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Australia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Thailand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Thailand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Thailand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Malaysia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Malaysia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Malaysia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Singapore Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Singapore Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Singapore. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

New Zealand Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The New Zealand Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for New Zealand. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Caribbean Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Caribbean Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Caribbean region. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Argentina Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Argentina Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Argentina. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Colombia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Colombia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Colombia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Chile Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Chile Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Chile. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Guatemala Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Guatemala Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Guatemala. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Dominican Republic Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Dominican Republic Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for the Dominican Republic. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Costa Rica Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Costa Rica Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Costa Rica. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Panama Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Panama Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Panama. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Mexico Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Mexico Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Mexico. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Brazil Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Brazil Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Brazil. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Turkey Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Turkey Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Turkey. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

Russia Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The Russia Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for Russia. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.

South Africa Surgical Procedure Volumes, 2018-2029
Published:
2022
Next Update:
Q2 2024
Deliverables:
excel report

The South Africa Surgical Procedure Volumes Dashboard provides historical and forecasted volumes from 2018 to 2029 for South Africa. Understand trends in procedure volume adoption and growth for over 200 procedures across 12 major procedure markets (Cardio, Ortho, General Surgery, OB/GYN, Urology and more). Data is updated and expanded annually to maintain a consistent pulse on the procedure utilization to empower strategic decisions on commercialization and new product development.
Schedule Meeting
Request Info
close
Video Transcription
close

Ed Muzio  0:05  
Good afternoon, everybody. I think at a real high level, there are two useful things we can do in this dialogue. One of them is talk about the possible organizational improvements that can happen. I think that's probably pertinent to the innovators and maybe some of the investors. And I think the other one is, there's sort of a, how does good external engagement look compared to not so good and external engagement of like what's possible? So I feel like then that have useful to some of the providers in the audience as well. So I feel like we could probably talk on both of those channels. Yeah, I


Todd Powell  0:35  
think so. And hi, everyone. That sounds good. I think, obviously, this isn't deeply rehearsed. But I think the the full scope of these topics are near and dear to our hearts. And we're excited to share some stories with you and do as we go, should we kind of entertain questions as they come to? Or do you want to kind of keep it?


Ed Muzio  0:57  
We can keep it old conversation, I think, yeah, we'll try and leave maybe 10 ish minutes every we've never had a meeting that went more than 28 minutes. So I feel like we're probably no, I think that's probably true. We're both talkers. So I for time, we do a lot. So maybe I'm thinking we start with what your need was, when we met, it's a good place to start. Sure, I


Todd Powell  1:13  
can do that again. So I'm Todd. I'm the president, CEO of RefleXion, medical. And the company has been around since 2009. But in many ways, it was kind of two guys, the classic two guys in a laptop story for the first five years, raised his first institutional capital in 2014, with sofinnova, and Venrock, as well as Pfizer, and then has had rounds kind of ever since then raised a little over $650 million. And we just set a little bit of context, right for the kind of the history of the company started treating our first patients with our novel form of therapy, which very quickly, this isn't about RefleXion, per se. So I'll keep this very quick, but which is a form of radiation therapy that uses injectable radiopharmaceuticals pet tracers. And as you probably appreciate how pet tracers work, they target and collect, in our case, cancer. And then we've built a machine that is uniquely and for the first time sensitive to those signals, and can fire right back at the origin of those signals, which is, again, the cancer itself. In fact, that's where the name RefleXion comes from. We started those actual therapeutic treatments last year in August, and now done that throughout our installed base. And we're seeing really fun and compelling clinical results already, with 50 publications, abstracts already accepted this year. So it's super exciting time for the companies, we kind of roll through science into kind of early commercial and clinical rollout, right, that's kind of the face of the company. Like Like, I think a lot of the companies you're you are all familiar with. And getting back to your question. And when did we start engaging in talking? It was probably 2018, maybe, right? Right, right around, then I joined the company in 2017, as a CEO to sort of transition the company from a team of physicists into a company, right, so to take a technology and sort of start to turn it into something that can be produced at scale. And, and to kind of do that I've been in med tech for about 30 years, and spent about a third of that as a software engineering then kind of moved into different kinds of management, stuff like that. But it was clear, when I joined the company, there were about 50 of us, and we were well capitalized and have continued to be well capitalized, we were growing fast, it's at we're a big expensive med tech, we have a, you know, 50,000 square foot factory that can make 125 of these big and heavy and expensive machines per year that machines kind of look like something you would shoot into space, you know. So it's kind of the typical big capital kind of story. And so, we're growing fast, hiring a lot of people, all different types of people, not just the physicists and engineers. And it was very clear to us during that phase of growth, or that was kind of the first knee of inflection in our growth, right. As we sort of transition to this phase, it was clear that if we did not embrace, proactively, deliberately a management methodology, and by that I don't mean a program or project management methodology, I mean, a decision making methodology, a strategy and management of the tactics to support a strategy and an early warning system related to all that so you can make course corrections quickly, because it was we all know, you have to it was clear that through that rapid growth of personnel that if we didn't proactively design a system, build a system and implement it, that system was going to grow organically, with or without us. And it would be a hodgepodge of half a dozen methodologies through well intentioned people that would join the company and it would just be sort of chaotic. And that was the situation we were in and I'll tell you a little bit more about how we came to know you and what that change, but that was the landscape at the time that you and I started talking.


Ed Muzio  4:55  
Yeah, that was the starting point. And so for me, kind of my background and context I was an engineer I started my career as a mechanical engineer. But I started my career at Intel back when there was no such thing as Intel computer engineers, so they just hired any engineer that could fog a mirror. And then they showed us when we got there, how to do it. So I was that for 10 years. And while I was there, I got kind of entrenched in their methodology that was back when they were among a small number of companies that were running a 10 year product roadmap with 18 month product releases, each of which was to release into a market that did not exist yet and wasn't clear that ever exist. So they just be super agile and adaptable, even though they were this giant company. And so I sort of grew up in that. Then I left I went into consulting and ended up forming a relationship with someone who became a mentor of mine, I started working on culture stuff, he had been working on kind of the sociological elements of what goes on high performing management, going back to like old school behavioral research from the 60s of guys with clipboards following managers around and saying, Is there something management? Does that makes things better? Or does it not matter? And there's some answers to that. And so that all came together for me. And so I've been, I've been doing this embodiment of this kind of work for around 10 years now, which is to answer the question of how do we need to run so that when we get bigger, we get faster? If I, some of you have met with me this week, if I've said this already to you, but if I take your computer, and I put a new processor in it, and I give it back to you, and I say to you, you it's now run by a larger, more complex system. So it'll be slower get used to it, you would fire me as your IT person, right. But that is a lot of what comes out of the org development and HR space around, what you should do is if you're a leader, you better start slowing down a little and kind of thread this needle between you gotta go slow to be accountable, but you got to go fast to stay alive. And it's kind of unfair, because it tips that about 25 to 50 people, and you better still be faster to that small. So, um, so that's my background. So I came into it, and here they are looking for a methodology. And I've been working on this, like, what happens when, you know, what do we have to do to make the company run?


Todd Powell  6:53  
That's right. And when I first started to get to know it, and I think we were introduced by a really sharp project manager that works for us. And he was at Kla, 10 core, right, we had worked together, obviously, a very big, sophisticated company that, that is very robust in its project management. And, and I think you worked with that individual to stand up some of this technology there. And, you know, as when I came to RefleXion, at that time, I had been part of small startups that grew into kind of big companies, and I've been, you know, run large teams all around the world. You know, and over those years, probably, like, a lot of you, I had the experience of kind of coming into a company, and then being responsible for a change management journey, where you might have had a company that had grown through maybe a dozen, maybe 20, acquisitions all around the world, you know, so you not only have geography and language to contend with, you have wildly different, you know, cultures and wildly different philosophies about what management even means, what decision making even means, what consensus means or doesn't mean, and how much is that important and, and, you know, happy to come in, and I was responsible for a change management journey, and one of those and was not a lot of fun. It was really brutal. And I wanted to get as far ahead of that pain with this company as I could. And it was like it, you know, so I'm kind of going into a bunch of physicists and engineers, super smart people, that RefleXion, best team I've ever had the honor of working with. And I'm saying, Look, we're going to implement a management methodology. And they're like, why, why would you do that? But you know, you couldn't pry it out of the company. Now, if you had to pry it out of the company, you couldn't, because people realize the efficiency of it the inherent effectiveness of having a common lexicon a common set of dashboards that everybody understands, we can, you know, and I'm probably jumping ahead, right, but you can, that's what we do. That's how all of our conversations tend to go. But, you know, we can move people between teams completely different a marketing person can jump over into a science deep team and advanced development team can pull back and deal with a support team that's dealing with the current release in the field. And they all have a common lexicon, they all have a common method for establishing and tracking progress towards goals and and a common tool set for escalating things when early warning signs go off. And they're gonna go off because there's a methodology to ensure they go off. You know, we all have this kind of common toolkit about how to stand up task forces and working groups and they live and then they're reported upon and then they die and we move on. And it's, it's turned out to be really slick. It's really stuck. Well, it's stuck Absolutely. To the point where in fact, we don't, it's got a book. Maybe you've seen it, and an ad talks about his company, and he's good at all this stuff, as I'm sure you're gonna pick up on, but we took it and made it our own. So we, we don't call it iterate now, which is the title of your book. And and in fact, when people say it, I kind of, you know, kind of smack them on it a little bit because we now call it the RefleXion management methodology, right? Because it's, we've taken the basic tenants of it, rolled it into our own framework. And that's just what we onboard people with now, when they when they start, they, you know, they get that as part of the onboarding process, we train that we do on site trainings, you've trained us so that we train ourselves on that now shifted from sort of a foreground role for a couple of years to a back away, and back away. Yeah, and that is your goal. And as your goal from the beginning,


Ed Muzio  10:31  
I'm supposed to get out. And that's engineers work themselves out of jobs and consultants work themselves into jobs. And I'm an engineer first. And that's, I think one of the unique things is that, I guess, yeah, I think that's


Todd Powell  10:40  
true. And that resonated with me, too, with my background, being in physics and engineering. And I immediately got the way Ed taught. And we're a super sciency engineer, kind of driven, like at our core, right? These are really smart people. And I knew that if I came at them with sort of the, I hope I'm not going to offend anybody. When I say McKinsey or anything, I'm so sorry. But you know, like, I've been in those big companies, too. And I've rolled out those multimillion dollar change management journeys driven by that kind of thing. And so I get that, totally. But I knew that if I came with anything that even smelled like that, it just wasn't going to fly. Right. But you came in and said, This is the beginning. And pretty quick. If this goes, well, you're not going to see me anymore. And it was like, I thought that was pretty cool. And I think and I think it's proven to earn the trust of the organization to kind of take those first leaps. And then it's the progress that kind of pays for the next leaps, right? People just kind of get it. Like I said, we I don't think we could pull it out of there. Now if we try to without that we would right


Ed Muzio  11:45  
now. And I think that's I mean, maybe this is both of those conversations, what's possible in this kind of work and what's possible in general, but, you know, I think they're the the HR slash HR thought leader universe has a machine where publishers go to conferences and listen for buzzwords, not knowing what they mean. And then get people to write books about those buzzwords and then push it back out there. And so it's an echo chamber in a lot of ways. I don't mean to say there are not good HR and OD thought leaders out there. I mean, to say there are many more of them than there are good ones. And so so that has led to a sort of an overall ethos of like, posters. So I'm supposed to leave my poster on Todd's wall with my footnote of Ed museo iterate with little r. And that is actually antithetical to real system change. Because the system I have taken to doing my personal career development by hanging out with people that understand how brains work, because organizational systems are a lot more like the complex neurological network of the brain than they are like the org chart we're using in HR, right. So if we're gonna make a system change, we have to get past the equivalent of the immune system. And one really good way to activate the immune system is to put a sign on it that says, this didn't come from here, right? This is from outside, and then I come in, you pay me and I leave and my poster stays. But that's all that stays. Right. So we were really intentional and and always are very intentional to not just yours, this is yours. Take it your language and


Todd Powell  13:01  
do it. Yeah. And it's and it's been fun. You know, I think Ed obviously has a style that I think resonates with me, I mean, it's a nerd. And I mean that in the most complimentary way. And our company is, you know, a bunch of nerds, right and myself included, and we get it, we kind of spoke a common language. And it was just a no nonsense approach to make people more efficient, so that they can focus their time and energy on the stuff they love to do. Where the management sort of is automatic. And I've been really just on obviously, I was pleased, right, you know, I mean, I wouldn't be here supporting a in talk, having a conversation with you about this unless I was and and you know, and it's funny, because I, when we first started talking about this panel, and we talked to Scott about doing this and things like that. It was a little like, I think we both sort of asked ourselves the question, Well, is there an audience here that will be interested in this? Or, you know, we were like, until five minutes ago, we're like, is anybody even going to write you know, as like, is anybody going to come? But what we told ourselves, and hopefully, it's true, I'm not trying to speak for anybody, maybe there, maybe there was just no other place to sit down or something, but but the, the, I, you should care about it. I just don't know how to say it. Right. But you should care about this stuff, whether you're running a company, I know you care about it, you know, but as an investor, you should care about it too, right? Because obviously, the one thing we all learn in working with investors is that you invest in people, right? You invest in teams. And and this methodology is like the grease between the gears of a team right and it pulls teams together. It makes them more efficient. It reduces the grind of those gears and you know, as an investor, you should want that and, but don't raise your price. I think as an investor, we want it to remain cost of Active too. And you aren't cost effective, especially when you compare it to some of those other things out there, where you leave the poster behind. Right? Well, yeah,


Ed Muzio  15:07  
you know, one of the things that that I think is, is probably worth mentioning here, just sort of what I'm actually putting in place, because it's really fairly simple. And this is, you know, this is where the engineer goes in me goes, you know, I say I can do this and a quarter. And other bigger name firm will say, it'll take two years and $10 million. And I go, I don't understand what you're doing for those two years, because we're just making a system change. All we're really doing and a fundamental level is usually 25 to 50 people, and I work with that size up to multinationals. You tip from, we all get into a room and look where we're going to do it, too. We now have layers and Todd's my boss's boss. So I'm, I'm going to make a status update to my boss, that looks good for Todd because either my boss is a little worried, or I'm a little worried or something. And so all of a sudden, Todd finds himself sitting in a staff meeting with a series of nine minute status updates. And so it becomes his job to look down at these updates and go, I think that was telling the truth. And now it's my job to put them together. Where what we what we really want is not something theatrical, like that. And so the change we make is to go know what's gonna happen in that meeting is they're all gonna come in, and they're gonna go, Look, we're going here together as a group. And right now my piece says, we're gonna end up here, and that's a difference. So I want to put this on the table right now, I think we should do this, this and this, to bring those two things together. And so that takes about three minutes instead of nine, and so on to make a decision about that we implement it. And so that decision breaks something else, or something else breaks on its own. And next week, we make a new decision. So we're putting more decisions in more frequent cycles. And you can speak to how that looked in your staff at that general thing we're trying to do.


Todd Powell  16:34  
Yeah, no, and thanks for that reminder, because it's funny, because we've been doing this now for a few years. Right. Right. Right. Yeah. And it's interesting that you reminded me of, of feeling that my team and I had when we started rolling this out, and it was immediate. And like a lot of startups, we all know, it's hard, right? It's incredibly hard. It's super stressful. And there's always something right, and what teams tend to do, and my experience of every startup I've been a part of, and I'm sure this is common among you, as well, it's easy to fall into a trap of a lot of storytelling, right? Because it's like, Hey, look at this incredible thing that I overcame over the last month, and you spend a lot of time, storytelling. And and and those stories are important because they bring a team together. And it's part of the fabric of self support that we I think we all appreciate is necessary in a startup trying to do something new and important and difficult. But if you don't tilt the equation, so that it's maybe 10%, storytelling 90% forward looking, you're you're not seeing around corners, you need to see, and then you know, you're you're going to react to things that you should be avoiding, to some degree, right, you'll never avoid everything, but you get the you get the idea. And I think we had started falling into that trap. And and we immediately noticed through the discipline of a relatively simple and straightforward methodology that we flipped that and the storytelling went down. In fact, it went so far down, I'll tell you what we did about in a minute. It went so far down that we spent all of our time forward looking, but we immediately were talking about the right things that were potentially months into the future. And we're doing that in a very consistent manner across a team, all staring at a single single kind of guiding point on the horizon in terms of goals, right. And, you know, I don't just mean one goal, like, you know, address late stage cancer that we're working on, but the detailed goals for that year, enable the to enable that, right. And, in fact, we got so good at not storytelling, that we had to add a section to our formal agenda called Cafe time. And it's a little just to do a little bit. So at the end of every agenda, there's a cafe slot, and it's just sort of like, Hey, you're hanging out with colleagues at a coffee shop, having an espresso or whatever, and it's an opportunity to share stories, right, that's, you know, in fact, you shouldn't be bringing up something that you should be bringing up in the bulk of the, of the weekly meeting. And, and it's turned out to be great. So people kind of separate that, and they kind of know. So it's not like we carved that out so much that people felt like they didn't have the opportunity for that storytime, but there's this the storytelling, the socialization of those events happen in a dedicated slot, which is proportionally appropriate, versus the bulk of the management methodology. You


Ed Muzio  19:24  
remember, Todd, I don't remember this or not. But like when we when I when I come in first, I observed some meetings. And then we do a big touchpoint. It's like a, it's like an on site off site. Except when you get back instead of being three days behind. You're three weeks ahead, because we actually do the work of the company for a few days with three layers. So Todd has people there people, but I watched a couple of meetings, your staff meeting, and it was all intelligent, good stuff around stuff that was coming up in the next I'd say four to six weeks, maybe eight to 10 weeks. And then we did that process and the first staff meeting after one of your people came in and went in 18 months we're gonna do the installs and if we don't solve this now it's not gonna work and you and I looked each other went, there it is. That's


Todd Powell  19:59  
right there. Yeah. And it was just really cool. Right? Yeah. And ever since then I


Ed Muzio  20:03  
think it was it was there. I think


Todd Powell  20:05  
so too, that that sort of solidified it. Right. And we got it. Yeah.


Ed Muzio  20:09  
So it's it's a, it's, it seems sort of strange. And part of the reason I'm so appreciative of Todd for doing this is normally my clients come in through referrals, because I say, I'll come in and fix this in three months. And you know, big name firm says two years and $20 million, and I seem like a crazy person, except then I come in to fix three months. So Todd calls his friend, like over there, that's how it usually works. So and it's only because it's not, as he said, it's not that complicated. The trick is to shift the behavior as collective habits. And I think that's a good thing to talk about is how the habits of your people changed. Yeah. And from that view, it


Todd Powell  20:42  
is that collective habit is totally right. I mean, now, it's, you know, there's part of this process is kind of a formal process for creating, updating and deploying goals across the entire company, which, you know, it's more than an all hands to say, this is what we're doing, right? I mean, it's sort of the, it's through the methodology that these things are memorialized, and artifacts are created that can be tracked in every single team meeting. And like, if, if I am behind on something like that, because I'm out raising capital, or any other things that we do, I mean, I have people nagging me for the, for the artifacts of this methodology, like right away. And it's, that tells you something too, right? I mean, people won't let this stuff go. They are counting on it that, you know, when we establish Task Force and working groups, we all know what a task force and a working group is. But there's a specific methodology for that, and our behavior, and people just expect it and we report on it. And they people know what that means. They understand the difference. There's a decision making timeline that, you know, there's all kinds of just sort of very pragmatic things that we understand, because


Ed Muzio  21:54  
actually, I think that so that the task force and working group, you guys have that language, now we do. But that's actually turns out to be a really important thing, right? So so if you're doing this, right, we're in Todd staff. And there's a decision to make, and we have to get you, you got to figure this out. And so if this is working in town, staff, Todd goes, you you take two weeks, go come back in the recommendation, we're putting on the agenda in two weeks. And that's called the task force, which is your only job as recommendation come back. And it's boring, and you do it all the time. And now Todd goes, we know what that is. But in the absence of that language, and structure, one of those people has to figure out on their own there's an issue, figure out who else to talk to get them to come to a meeting. And so we are tasking people with inventing management and leadership on top of their job of doing it, and it's hard enough to do it right. So once you get that in place, it's boring. We stand up, we tear it down, and then it goes on. That's


Todd Powell  22:43  
right. And I think it's important to remind ourselves, and we sort of struggled with this, too, it's like, no, well, no, like, you know, among our physics team, we like to look at challenges and solve challenges in this way. And in our market organization, we want to do it that way. And our service team does it this way. And that was just terribly inefficient, right. And getting to a point where we were we formalized, even if it was kind of a light touch formality. But to have that a lexicon, an approach, and sort of a template to use cross functionally, has allowed the service person to be on the physics team and drafted in and the physical physics person to go draft into a service team, and just not be caught off guard, like, Wait, what are we doing? You know, it's just like, people get it. And they can flow it, we found our ability to have teams be more fungible. In a cross functional setting, because of this, it's enabled project management to have a better footing in this process, because they can reach across as well. Yeah, I just haven't seen a downside. And I'm really glad we did it. It's been a super productive journey. And and it's now part of the fabric of what we do.


Ed Muzio  23:54  
Yeah, yeah. And I think that the higher level, I think the other conversation we're having about what's what is, what's what can be good about an external engagement is even in a whole different space, I think, you know, part of what we're trying to do with what I'm doing is to say it is very light, right? So in my multinational clients, there could be templates that are pages long. The template toss talking about his four letters, literally, make sure you cover these four things and do it in less than three minutes. So we didn't on a single page. Yeah, on a single page, right. And so so we didn't say like, your marketing department likes asana and the other people like, that's fine, Keep it keep it you're doing for sure. Which in bigger companies, they they kind of get heavy with it. But being able to stay late is important. I think. I


Todd Powell  24:30  
think it's definitely important to be able to stay late. I agree. So


Ed Muzio  24:33  
I think we're close to the q&a part is I guess I want to ask you before we do that, from the lens of kind of behaviors, and you're kind of in a sense, your remote from a lot of what goes on the next level down, but do you see what do you see as systematic behaviors now that are almost like unquestioned, but you can look back to before we did it and say those weren't like that. I


Todd Powell  24:58  
feel like we're We're much better at looking around corners. Like I feel like because of this methodology, and there's just the mindset of, of spending, you know, kind of 90% of our team engagement. Looking for ways we won't achieve a goal, whether it's a high goal, a low goal that feeds into a high goal, we understand the linkage between goals, every team has to quantify their goals. There's terminology for it, I won't get into, that's part of the methodology but, and then associate them to the higher level goals. So every single thing that every single thing in the company that everybody works on, no matter what function can be directly tied back to one or more corporate goals that are maintained. And if and if there's any reason to believe we aren't going to achieve one of the things down here it because of the methodology will ripple all the way up. And people like to do that, you know, that we sort of measure whether or not we're being honest with ourselves based on the number of these sort of one page things that are these early warning signs, how often they come up, and they, they come up a lot, it's, I think the early warning system is in place, right? It doesn't keep things from going wrong. But I feel like we're reacting to what's wrong faster, then I have seen in other companies that did not have a consistent methodology across all functions, right.


Ed Muzio  26:23  
And I think that one thing I want to say about that the methodology pieces, and this is pretty important, I think, I don't know if I should name the one of the other bodies of work around goal setting, but But I will say it's really good. There's a body of work called OKRs. Maybe you've read the book, it's really very good. It comes from the same initial research and information that they generate content comes from. And that book is literally like my chapter three, I think. So it is very consistent with what I'm doing the benefit of that book, as it gets much deeper into how to do that part of it. Well, the downside of that book is there is a way to read it that makes it sound like as long as you get the goals, right, everything else falls into place. And that's not actually true. And I've seen time and again, this is especially true in the larger organizations, or people that have come out a large organization that you were doing this, but some of these guys in your seat will do this, where it's like, we came from one of the fewer high functioning large organizations. And now I'm going to do it here. And what's most visible is linked goals like OKRs. And the second thing that's most visible is regular meetings. And so I've seen multiple times executive, I don't understand I put linked goals and regular meetings in place. And it got more bureaucratic. Those two things by themselves, add bureaucracy, and they add, I think about a 15 to 18% tax on the organization. If you just do that, if you do the thing, Todd's talking about just the early warning system and the decision making and the cycling of raising issues, so that you're taking bite by bite out of the work, that's iterate, right, that's, that's the piece that makes it work, right.


Todd Powell  27:41  
And I just think there's, there's just certain cultural things like the thing that I liked about this, and again, kind of refreshing my memory of some of the decision process that I went through when we took this on, as, at the end of the day, this is a change management journey, right. And we've all done change management projects. And, and there are great ways to do those and terrible ways to do those. And we've probably all lived through those examples. The thing that I really liked about this approach, and I found it common among every good change management journey I've been a part of is that it was relatively simple, right? It was straightforward, it was not tool based, like where you get a tool, and it's a software thing, and you have to do it every time I have a thought or a decision, I'd have to document in a tool that's awkward and hard to use. And then everybody's got to learn the tool. It just wasn't. These are like one page Word document artifacts, right, that are just simple. Because it was more it was like a, it was a change management process that started with a cultural impact, supported by simple kind of process improvements and methodologies and kind of a lexicon of vocabulary. Versus like, Oh, here's the ED software tool, and y'all gotta use that we need an annual subscription, you know, and all it was none of that. And so I, I felt like because it led with culture. It has been supportive of our culture and amplifying of our culture. And what I tell every employee that has ever worked at RefleXion, I and I literally mean it and you could ask anybody that's there. I want this to be the best job they've ever had, no matter what happens, I want it to be the best job they've ever had for the outcome of our patients for the outcome of our clinical partners and for the outcome of their career and the advancement of their own career. And, you know, that's super important to me, it's super important to my team. And part of that I think the biggest part of that is that trance they and they would tell you, I think if you ask them that they believe that RefleXion is among the most transparent companies they've ever worked for. And that's my goal, because I was part of great magical startups that were everybody knew everything. And we were all in it together. And it was the kind of classic Silicon Valley thing. And I've been parts of big bureaucratic organizations too, and I knew I just hated that and did not want to I want to do everything I could to go in the opposite direction to that. And so we hit this hard from that cultural perspective through the lens of transparency. And, and I think because this is a simple and easy to implement tool based on common sense, that appeals to people in that manner, it's amplified our transparency. And I think that's probably why people like it, right? They kind of know what we're doing. They know why we're doing it. They know what the risks are, they know how we're managing the risks, because there's a common set of things that we all share and publish lies. And you know, what I mean, it's just part of what we do. And I think that's, you know, at the end of the day, I mean, what more could I want from how a management team reacts, interact with each


Ed Muzio  30:40  
other. And as hard as it sounds on the front end to say, we're gonna build a culture where people bring issues early and never go on wondering if there's really no, everything's fine in my area, look over there, you know, on the flip side of it, that creates the transparency that love and retention they love, because it's like, Oh, when I have a problem, there's a whole bunch of peers waiting for me to bring it to them to help me as early as I can. And they say thank you, and I bring it because they want to solve it sooner. And that's a that's a big flip of what's normally there. I don't think by the way on the on this, those of you are service providers, what makes a good engagement? When the guy who hires you says I'd like this to be one of your best effort, engagements to which Todd said to me when you hired me, that's a good sign. That's good manners. Yeah, no, and I, you know, I also I, I am lucky in that usually, my CEO clients self select out if they're trying to run dictatorships, or if they're overly obsessed with their own power, you know, because they hear me talking and go, I don't want to do that. But, you know, Todd was definitely all the way the other direction of like, someone who's saying, like, I see the importance of this, and I want to make sure we do this right. And it's worth a little bit investment wants to get it right, versus trying to hack our way through it and get it wrong a few times. And I think that's a good, a good, yeah.


Todd Powell  31:42  
And especially, like, I don't want to take any, any excess credit for that, right. I mean, I think it's because it's just immediately identifiable to the people that are going through the change, you know, basic tenant of change management, right? Celebrate wins early, right and get every you know, so that you can kind of go, wow, this is worth doing some change management journeys, you got to wait a long time before you see some wins, right. So you're kind of hoping that you have enough momentum to sort of push through the first kind of break the first wall of ice, but we started seeing wins right away, cultural wins, transparency wins. And and I think that has created a momentum that the company has continued to build around. And it


Ed Muzio  32:22  
hasn't, it was its fundraising, we got we got into COVID, a little bit. And so I ended up staying around a little differently with RefleXion than I would otherwise. Which was really cool for me, I got to see, like, I got to really see in real life, something happened the executive team, and then the next level down copied it, not because anyone told them to just because it made sense. And next level down, like it was like, Oh, they're they're all doing it. Like I got to see the theory of like cultural replication go down, which by the way, if you are an innovator, and you're running a team of any size, run your team as clean as you can, because they are all bad photocopies on the way down, right, don't get worse. So do your best to have to be cleaned. Because they will they will do it. Well, if you do it well. But if you do it, if you do it, but not clearly, it just gets it just gets fuzzier. So


Todd Powell  32:59  
that's all I got. I don't know if you have anything else. But I mean, I know we're getting close on time. But um, this is probably a different kind of panel, then you've come to at LSI. It's a different kind of panel that I've been on at LSI. But he brought, but you know, I hope you found it interesting. And so I for one want to thank you for your time. Yeah,


Ed Muzio  33:22  
I thank you also for your time. And thank you, Todd for for doing this. This has been a fun experience this way too. We have a few minutes left. If anyone wants to ask questions we can I think do it right. And then wait. Yeah, yeah. We'll go across those. Yeah, there are Oh, good. There you go. Can you hear me?


Audience Question  33:38  
Is there a meta process? Which is to say like, every amount of time or every incident or whatever, we pause and we think, is this decision framework working? Do we need to change anything about it? Or? Right? Is there any of that built into the


Todd Powell  33:52  
framework? I mean, not all answer my interpretation of that you will. Yes, is the short answer. And it's continuous. The book is called iterate, and it's based on and the methodology that we have adopted is based on continuous iterations with then current information. So whenever new information comes up, whether it's a lack of progress to challenge something that needs to be fixed, or corrected or influenced, otherwise, you won't achieve that goal. That's when it comes up. So it's sort of not like, Okay, see you next quarter or even see you next month. It's whenever it needs to come up. Exactly, you interpret I think that's right. I


Ed Muzio  34:30  
think, you know, the thing I would say, from my perspective, is I always say I only know two things, what has to happen and how to get it to happen. So if you read the book and do it, that's all you need. Except you're right. The one thing I didn't put in the book that I will put the next edition is there should be a debrief process every so often to just check out what's going and so if


Todd Powell  34:46  
that's what you're referring to sort of the broader process, health check on the process. We do that too. And so there is an opportunity and you know, fortunately my team has no trouble raising objections. And so they're We that that comes up a lot, too.


Audience Question  35:02  
And can I ask a quick follow up? Is there some memorialization of the decisions and some annotation of how you arrived at that decision? And is that somewhere? So it's institutionalized? Somehow


Ed Muzio  35:13  
decisions within the meetings? Or the decisions or decisions that would change?


Audience Question  35:17  
You know, something about? Yeah, yes. Yeah, we do that, too. That's part of it. And there's, there's the one pagers or do you have like a separate log,


Todd Powell  35:24  
we have an ongoing set of very quick minutes, especially around decisions, task force working group input output. So that all that's memorialized. So if we go back six months later, we've all been there, right? And you're like, why did we pick that? Again, you can go back and there's


Ed Muzio  35:36  
some very block and tackle stuff built in here as well, some high level stuff, I want to answer a question you didn't ask. That's very related. Because I think it's super cool. One thing these guys did, which now I recommend is the best method, if the company is into it is when we got done you, you created a little brochure, and it said who we are matters, and it was mission vision values. And then the next page, it said, how we work matters. And it was RefleXion management methodology. So that's also memorialized, and they did it in a way of like, when someone comes in, like, here's the culture, and it's very clear, very clear, very short, so that they so that everyone coming in the door understands why and what why. Yeah, thank you over there. I think


Todd Powell  36:06  
I was just curious how you're triaging these early warnings as they come in. Every team does this, but I'll speak to my team. So so we have our weekly stand ups every Tuesday. We deliberately do them on Tuesdays so that the team is in the office on Monday might pick up something that wouldn't otherwise pick up. And then by Friday evening, they have to have submitted everything that they would like to raise in the Tuesday meeting, including any issues that all look at and I decide one of the one of the parts of the methodology is, what are what are my deliberate active decisions versus you know, what, sometimes the team is trying to influence me to make a decision? And it needs to be clear that I'm the decider. I'm on the hook for that. Right. And, and so that's one, it's kind of an administrative example. But I decide what's going to be on the agenda or not, because I might delay something because I want some additional information to come in or anything like that. Yeah, so there is a triaging opportunity. So, but it works out pretty quickly, it's been rare that I say we're going to delay that one a week, or a few days based on some new information that they may not be aware of, or something like that. That's those are the exceptions. But we do have that opportunity to


Ed Muzio  37:23  
one of the things that I've seen that relates to that is, and I don't know how much this was the case with you guys a little bit. I think sometimes it's more pronounced. Sometimes there's this effect of like, oh, it's staff, what are we gonna talk about? And when we get it up and running the right way, it's like, staff populates itself, because your people put it a bunch of issues, you're picking the highest priority one. And oh, by the way, three weeks ago, you had an issue, you put it on the agenda for today to come back with recommendations fast.


Todd Powell  37:43  
Right? And so we're just like going around the table just like digging, digging, digging, digging, you know, I mean, it's really efficient. I mean, we, we still meet often, but but we get through a lot fast and efficiently.


Ed Muzio  37:56  
I had another client that they they did the process. At the end, the leader pointed at somebody and said, You've been here the longest, what do you see as the difference? And this was a virtual one, it was worldwide group. And we do it virtually. And, and she goes, I just watched a recording of one of our staff meeting six months ago, and she goes, we weren't doing very much. And then like, in real time, she goes, Wait, Ed, you knew? And I was like, Well, I mean, you know, you're getting more done now. And that's, you know, there was there's potential there. Right. But it is it really is a it's hard to describe the level of like, how much more happens per cycle? Yeah, but


Todd Powell  38:24  
it's, it's real. Yeah.


Audience Question  38:28  
Thanks so much. Um, one of the things I'm struggling to understand is how do you get people out of that star startup, you know, firefighting phase, if you like, you're always looking at the thing that's right in front of you that needs to get done, and really get them to think about, well, what matters in 18 months that I have to address today.


Ed Muzio  38:46  
I don't think you push them to 18 months, so much as you give them away to raise the issues, that's part of it, that accelerator is is like, you have to get those cleared, you can't say don't worry about this, look out there, you have to go we're gonna start to clear issues faster. And then they move out themselves, I think,


Todd Powell  39:00  
yeah, I think I think there's a there's a push and pull. And they both happen, right? The pool is that look, we're going to shift from storytelling 80% of the time, to storytelling 10% of the time, and everything else is got to be forward looking, which by definition means we have to have goals, which by definition means we have to talk about the tactics to support those goals. Right. And so then there's a strategy session to produce the goals in the first place. And so, you know, you sort of inherently the poll is that the team are forced to think about the future more now the future might be a week, a month a day, six months, whatever, right? So it kind of depends on the function and where the company is obviously. But but the push is that at least in my case, like the reason I was talking about wanting to do this was because I saw that if we didn't there was gonna be a problem right? And we already started to feel pockets of it and the way you know how it goes right? Teams express their present frustration not to say like, Hey, we don't have you know, company Why goals are they don't say that they say, We don't feel aligned cross functionally, it's that kind of thing, right. And so sufficient pain gathers in the organization to the point where it is motivated for change. And that's the that's the pain you tap into, so that they're pushing. And then the poll is the goal setting and the tactics, I think it's both and and so if you if you can emphasize that pain, and you have the companies trust, and I'm sure you do, you know, you have the opportunity to kind of try something right. And as long as you get the early wins, quick buy in, it starts to build a virtuous bit of momentum behind it. Does that make sense? Yeah, so


Ed Muzio  40:37  
we're hitting the time wall here, Todd, thank you so much for this. I'm gonna sign a purchase at my table over by registration. I also hit 10 books under the table. So if you don't have one yet, I might have one for you. But Todd, thank you so much. This has been fun and glad to thanks again. Thank you


 

back Back to all attendees close
Ed Muzio

Ed Muzio

Group Harmonics

I'm an engineer-turned-management-consultant, and for 20 years I've been providing analytical solutions to the challenges of running organizations of all sizes. If my information and links here seem like they'd be useful to you, let's connect.

  • linkedin
  • Website website
back Back to all attendees close

Ed Muzio

Group Harmonics

I'm an engineer-turned-management-consultant, and for 20 years I've been providing analytical solutions to the challenges of running organizations of all sizes. If my information and links here seem like they'd be useful to you, let's connect.

  • linkedin
  • Website website
Ed Muzio
back Back to all attendees close
Todd Powell

Todd Powell

RefleXion Medical

Todd has over 25 years of experience in medical-technology & innovation leadership with multi-national, teams of all sizes from startups to over 1200 employees. IPO experience along with numerous mergers, acquisitions, technology and commercial partnerships.

He has a particular ability to formulate and nurture a vision and the strategy to commercially realize it through thoughtfully developed, cross-functional teams at the highest organizational levels.

Through his experience and industry relationships, Todd has a deep understanding of the complexities and nuance of the oncology market including the rapidly changing clinical, financial and operational challenges within healthcare networks.

  • linkedin
  • Website website
back Back to all attendees close

Todd Powell

RefleXion Medical

Todd has over 25 years of experience in medical-technology & innovation leadership with multi-national, teams of all sizes from startups to over 1200 employees. IPO experience along with numerous mergers, acquisitions, technology and commercial partnerships.

He has a particular ability to formulate and nurture a vision and the strategy to commercially realize it through thoughtfully developed, cross-functional teams at the highest organizational levels.

Through his experience and industry relationships, Todd has a deep understanding of the complexities and nuance of the oncology market including the rapidly changing clinical, financial and operational challenges within healthcare networks.

  • linkedin
  • Website website
Todd Powell